Niagen Bioscience Inc NAGE Q1 2026 Earnings Modest EPS Beat Highlights Operational Discipline Amid Quiet Revenue Reporting Visa Restrictions Push US Companies to Develop Contingency Plans as 80 Report Immigrant Executives ANRO Q1 2026 Earnings EPS Misses Estimates but Shares Climb on Pipeline Hopes AIs Limits The Rise of HALO Stocks and a New ETF for HumanCentric Investing SW Q1 2026 Earnings EPS Misses Estimates Amid Cost Pressures Stock Edges Higher Paul McCartney Appears on Stephen Colberts Final Late Show Episode Jackson Financial JXN Q1 2026 Earnings EPS Misses Consensus by Nearly 15 as Stock Declines